Literature DB >> 2380504

Effects of vitamin D3 metabolites on thyrotropin secretion from rat pituitary cells in culture.

K Törnquist1, L Forss, C Lamberg-Allardt.   

Abstract

The effects of several vitamin D3 metabolites on TSH secretion were investigated using rat pituitary cells in culture. After a 24-h incubation in Dulbecco's medium, only 25,26-dihydroxyvitamin D3 [25,26(OH)2D3] at 10(-6) M increased the basal TSH secretion (36% above control). The TRH-induced TSH secretion increased dose-dependently with increasing concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] showing a significant increase at 10(-8) M (41% above control). At 10(-5) M 25,26(OH)2D3 the TRH-stimulated TSH secretion was also increased (63% above control). In medium containing charcoal-treated serum, 1, 24,25-trihydroxyvitamin D3 [1,24,25(OH)3D3] decreased the TRH-induced TSH secretion dose dependently (34% below control at 10(-8) M), while the effects of both 1,25(OH)2D3 and 25,26(OH)2D3 were blunted. Our results indicate that several vitamin D3 metabolites may affect pituitary TSH secretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380504     DOI: 10.1007/bf03350686

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Attenuation of thyroid hormone action by 1,25-dihydroxyvitamin D3 in pituitary cells.

Authors:  H Kaji; P M Hinkle
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

2.  Effect of 1,25(OH)2D3 on the TSH secretion from rat pituitary cells.

Authors:  K Törnquist; C Lamberg-Allardt
Journal:  Horm Metab Res       Date:  1986-01       Impact factor: 2.936

3.  Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.

Authors:  M G Caron; M Beaulieu; V Raymond; B Gagné; J Drouin; R J Lefkowitz; F Labrie
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

4.  Effects of vitamin D3 metabolites on production of prolactin and growth hormone in rat pituitary cells.

Authors:  E Haug; J I Pedersen; K M Gautvik
Journal:  Mol Cell Endocrinol       Date:  1982-09       Impact factor: 4.102

5.  24, 25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation.

Authors:  A Ornoy; D Goodwin; D Noff; S Edelstein
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

6.  Dual actions of 1,25-dihydroxycholecalciferol on intracellular Ca2+ in GH4C1 cells: evidence for effects on voltage-operated Ca2+ channels and Na+/Ca2+ exchange.

Authors:  K Tornquist; A H Tashjian
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

7.  Demonstration of circulating 1,24,25-trihydroxyvitamin D3 in man by radioimmunoassay.

Authors:  T L Clemens; L J Fraher; L M Sandler; J L O'Riordan
Journal:  Clin Endocrinol (Oxf)       Date:  1982-04       Impact factor: 3.478

8.  Effects of vitamin D metabolites on healing of low phosphate, vitamin D-deficient induced rickets in rats.

Authors:  I Atkin; J C Pita; A Ornoy; A Agundez; G Castiglione; D S Howell
Journal:  Bone       Date:  1985       Impact factor: 4.398

9.  Thyrotropes in the pituitary are target cells for 1,25 dihydroxy vitamin D3.

Authors:  M Sar; W E Stumpf; H F DeLuca
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

10.  Vitamin D stimulates prolactin synthesis by GH4C1 cells incubated in chemically defined medium.

Authors:  J D Wark; A H Tashjian
Journal:  Endocrinology       Date:  1982-11       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.